Parker, William A E <br/><br/>
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome.  [electronic resource] 

 -  Platelets  2019 
 - 148-157 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1369-1635 
<br/><br/><label>Standard No.: </label>10.1080/09537104.2019.1572880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Aspirin--pharmacology<br/>Female<br/>Hemostasis<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--pharmacology